New antiviral pill could shorten your next cold
NCT ID NCT04682444
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the antiviral drug Amizon (enisamium iodide) can help adults with colds or flu feel better faster. One hundred adults aged 18 to 60 took either Amizon or a placebo pill for 7 days, starting within a day of their first symptoms. Researchers tracked symptoms like fever, cough, and runny nose, as well as lab tests, to see if the drug improved recovery compared to placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Amizon (enisamium iodide) tablets
- What this could lead to
- If it works, this could provide a treatment option for common colds and flu, reducing symptom duration and severity.
- What could go wrong
- This is a small, early-phase trial with only 100 participants, so results may not apply broadly. The drug is compared to placebo, and many cold/flu treatments show limited benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY VIRAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.